Cytomegalic Inclusion Disease
Symptoms, Doctors, Treatments, Advances & More

Cytomegalic Inclusion Disease Overview

Save information for later
Sign Up

Learn About Cytomegalic Inclusion Disease

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Cytomegalic Inclusion Disease Local Doctors?
Elite in Cytomegalic Inclusion Disease
Infectious Disease
Elite in Cytomegalic Inclusion Disease
Infectious Disease

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville

10751 Falls Road, Falls Concourse STE 412, Falls Concourse STE 412, 
Lutherville, MD 
Languages Spoken:
English
Offers Telehealth

Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as an Elite provider by MediFind in the treatment of Cytomegalic Inclusion Disease. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Severe Acute Respiratory Syndrome (SARS). Dr. Avery is board certified in American Board Of Internal Medicine.

Elite in Cytomegalic Inclusion Disease
Infectious Disease
Elite in Cytomegalic Inclusion Disease
Infectious Disease

MacGregor Infection Medicine And Travel Program

3400 Civic Center Boulevard, South Pavilion, 4th Floor, 
Philadelphia, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Emily Blumberg is an Infectious Disease provider practicing medicine in Philadelphia, Pennsylvania. Dr. Blumberg is rated as an Elite provider by MediFind in the treatment of Cytomegalic Inclusion Disease. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Cytomegalovirus Infection, Cytomegalic Inclusion Disease, HIV/AIDS, Kidney Transplant, and Liver Transplant. Dr. Blumberg is board certified in Internal Medicine, 1984. Dr. Blumberg is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Cytomegalic Inclusion Disease
General Practice
Elite in Cytomegalic Inclusion Disease
General Practice

Office

1310 24th Ave S, 
Nashville, TN 
Languages Spoken:
English

James Goldenring is a primary care provider, practicing in General Practice in Nashville, Tennessee. Dr. Goldenring is rated as an Elite provider by MediFind in the treatment of Cytomegalic Inclusion Disease. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Microvillus Inclusion Disease, Cytomegalic Inclusion Disease, Stomach Cancer, and Menetrier Disease.

What are the latest Cytomegalic Inclusion Disease Clinical Trials?
Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Summary: This phase I trial tests the feasibility and safety of genetically modified cytotoxic T-lymphocytes in controlling infections caused by adenovirus (ADV), BK virus (BKV), cytomegalovirus (CMV), JC virus (JCV), or COVID-19 in immunocompromised patients with cancer. Viral infections are a leading cause of morbidity and mortality after hematopoietic stem cell transplantation, and therapeutic options f...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase I Pharmacokinetic and Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus Disease

Summary: This is a Phase 1 single-arm open-label study of letermovir in neonates with symptomatic congenital Cytomegalovirus (CMV) disease. There will be two groups enrolled. Group 1 will be comprised of 4 subjects. Following documentation study inclusion and signing of informed consent, Group 1 subjects will receive one dose of oral letermovir (Study Day 0), using the dose bands. A full pharmacokinetics (...